Remove Patient Care Remove Pharmaceutical Companies Remove Specialty Pharmacies
article thumbnail

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacy Times

This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.

article thumbnail

APPE Rotation with PQA

PQA

She currently serves as the National Executive Committee (NEC) Student President under the National Association of Specialty Pharmacy (NASP), promoting advocacy of the field of specialty pharmacy to students around the country. What inspired you to complete an APPE rotation in association management?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

17 Different Contract Pharmacy Policies and Counting

Omnicell

Ted Slafsky Founder and Principal of Wexford Solutions, Publisher, 340B Report In the past 18 months, the 340B contract pharmacy program has seemingly fractured into 17 programs, one governed by the federal government and 16 others with their own standards determined by pharmaceutical manufacturers.

article thumbnail

PQA Welcomes 11 New Members

PQA

Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.

article thumbnail

PQA Welcomes 11 New Members

PQA

Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.

article thumbnail

Q&A with PQA Board Chair James Kirby

PQA

I still oversee program development today but am now focused on health care innovation and collaborating with payers, pharmaceutical companies, providers, and patients to bring these holistic solutions to market. I have worked in both the payer and provider segments, including hospital, mail, and specialty pharmacy.